Illumina is a U.S.-based global leader in genomics and precision health, known for developing innovative DNA sequencing and array-based technologies. With a mission to unlock the power of the genome, Illumina empowers scientists, researchers, and clinicians to make groundbreaking discoveries that transform healthcare. Its technologies fuel progress in areas such as oncology, infectious and genetic diseases, reproductive health, and beyond. At the core of Illumina’s vision is a belief in collaboration, integrity, and accessibility. The company is committed to making genomics more affordable and inclusive, broadening its impact across communities and around the globe. By continually redefining what’s possible, Illumina is shaping the future of life-changing precision medicine.